A Phase II Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer (47-02-001).
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2015
At a glance
- Drugs PG 11047 (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 18 Apr 2009 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 06 Nov 2006 New trial record.